Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,710.00
-100.00 (-1.28%)
At close: Aug 21, 2026

Daewon Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
23,72847,19617,05729,98226,97041,697
Short-Term Investments
42,45629,27929,05147.7120,03613,123
Cash & Short-Term Investments
66,18576,47546,10830,03047,00654,820
Cash Growth
54.58%65.86%53.54%-36.11%-14.26%421.08%
Accounts Receivable
53,77777,11973,35570,60262,53352,102
Other Receivables
3,6392,5914,3172,5803,9062,363
Receivables
57,99980,29377,87773,38266,84054,584
Inventory
105,15597,832113,166105,07891,84769,690
Prepaid Expenses
2,119759.55716.31488.39426.61353.29
Other Current Assets
2,1011,2431,486314.561,165929.46
Total Current Assets
233,559256,603239,353209,293207,284180,377
Property, Plant & Equipment
220,524222,902208,378160,092158,912166,674
Long-Term Investments
39,82956,89848,62184,64736,44328,081
Goodwill
-6,0005,5497,25411,32811,549
Other Intangible Assets
65,45930,69329,19116,12113,60313,916
Long-Term Deferred Tax Assets
11,44012,4528,5407,9856,6949,616
Long-Term Deferred Charges
-25,78320,05718,09615,14214,977
Other Long-Term Assets
2,5182,32023,7014,5104,1444,390
Total Assets
573,328613,651583,389507,998453,550429,580

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
20,96630,28320,91320,91019,58317,222
Accrued Expenses
5,0226,2265,6864,8854,3523,741
Short-Term Debt
89,074105,740106,03569,65152,76842,543
Current Portion of Long-Term Debt
35,8289,47712,91739,8039,2848,822
Current Portion of Leases
2,2041,8641,8001,1231,344362.95
Current Income Taxes Payable
2,118487.514,4032,4854,9134,367
Other Current Liabilities
52,65862,26149,02343,83335,90325,019
Total Current Liabilities
207,869216,337200,776182,690128,146102,076
Long-Term Debt
59,53182,87063,62634,57552,11969,625
Long-Term Leases
2,5142,0852,863897.72961.422,616
Pension & Post-Retirement Benefits
27,68231,20527,79225,49723,47836,780
Other Long-Term Liabilities
06,5763,75373.58080
Total Liabilities
297,597339,073298,811243,734204,785211,176

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
11,21411,21411,21411,09510,98210,612
Additional Paid-In Capital
17,96217,96217,16113,48311,7899,530
Retained Earnings
255,877251,407262,077255,790241,595204,827
Treasury Stock
-15,063-15,063-15,063-15,063-15,063-8,891
Comprehensive Income & Other
-2,311398.29-104.76892.921,6433,221
Total Common Equity
267,679265,918275,285266,199250,947219,299
Minority Interest
8,0528,6609,294-1,934-2,182-894.85
Shareholders' Equity
275,731274,578284,578264,264248,765218,404
Total Liabilities & Equity
573,328613,651583,389507,998453,550429,580

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
189,151202,034187,241146,050116,476123,968
Net Cash (Debt)
-122,966-125,559-141,133-116,020-69,471-69,148
Net Cash Growth
------
Net Cash Per Share
-5724.48-5858.09-6629.05-5356.37-3175.72-3258.76
Filing Date Shares Outstanding
21.4321.4321.4321.220.9720.6
Total Common Shares Outstanding
21.4321.4321.4321.220.9721.22
Working Capital
25,68940,26638,57726,60379,13778,301
Book Value Per Share
12488.8612406.7012843.7012558.8911966.6610335.27
Tangible Book Value
202,221229,226240,544242,823226,017193,833
Tangible Book Value Per Share
9434.8210694.7711222.8511456.0710777.829135.12
Land
-51,41451,41436,95736,95737,055
Buildings
-145,397122,341107,803107,71079,558
Machinery
-138,403114,900101,791100,14941,553
Construction In Progress
-11,63029,61310,692778.361,585